LUM and diabetes mellitus: Our findings implicate lumican as a potential mediator of cellular metabolic defects in DM, including impaired adipogenesis, increased intracellular lipid storage and lipolysis, and IR, and suggest that this understudied ECM molecule is a putative link mediating ECM regulation of adipocyte metabolism.